| Smart material platforms for miniaturized devices: implications in disease models and diagnostics R Verma, RR Adhikary, R Banerjee Lab on a Chip 16 (11), 1978-1992, 2016 | 30 | 2016 |
| A temporal study on fate of Al2O3 nanoparticles in a fresh water microcosm at environmentally relevant low concentrations S Pakrashi, S Dalai, B Sneha, N Chandrasekaran, A Mukherjee Ecotoxicology and environmental safety 84, 70-77, 2012 | 27 | 2012 |
| Evaluating glycemic control in patients of South Asian origin with type 2 diabetes using a digital therapeutic platform: analysis of real-world data A Krishnakumar, R Verma, R Chawla, A Sosale, B Saboo, S Joshi, ... Journal of Medical Internet Research 23 (3), e17908, 2021 | 25 | 2021 |
| Fitterfly Diabetes CGM Digital therapeutics program for glycemic control and weight management in people with type 2 diabetes mellitus: real-world effectiveness evaluation S Joshi, R Verma, T Lathia, C Selvan, S Tanna, A Saraf, M Tiwaskar, ... JMIR diabetes 8, e43292, 2023 | 5 | 2023 |
| Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days R Verma, S Bhardwaj, T Lathia, S Kalra, R Ranadive, S Tanna, ... International Journal of Diabetes in Developing Countries 43 (3), 425-432, 2023 | 3 | 2023 |
| Video Call-based Fitness Assessment shows Poor Fitness in People with Type II Diabetes: Findings from Diabefly Digital Therapeutics Program. M Bhagat, A Mandlekar, R Verma, T Lathia, S Tanna, A Saraf, ... The Journal of the Association of Physicians of India 70 (7), 11-12, 2022 | 1 | 2022 |
| 601-P: Participation in diabefly program and significant reduction in diabetes distress and improvement in motivation and attitude towards changing health among people with … N Verma, T Lathia, P Vasan, N Gupta, R Verma, S Kalra, MV Padsalge, ... Diabetes 71 (Supplement_1), 2022 | 1 | 2022 |
| 703-P: Significant weight reduction and improvement in glycemic control among people with T2D after participation in diabefly digital therapeutics program R Verma, MA Khader, T LATHIA, SR TANNA, S KOTHARI, P THAKKAR, ... Diabetes 71 (Supplement_1), 2022 | 1 | 2022 |
| Evaluation of personalized glycemic response based diabefly-pro digital therapeutics program for improvement in time in range in people with type 2 diabetes R Verma, T Lathia, A Saraf, M Shenoy, S Tanna, V Raskar, M Joshi, ... DIABETES TECHNOLOGY & THERAPEUTICS 24, A137-A137, 2022 | 1 | 2022 |
| Automatic rigging of 3D models with stacked hourglass networks and descriptors R Verma, S Mittal, S Pawar, M Sharma, S Goel, VHC Albuquerque AIP Conference Proceedings 2919 (1), 2024 | | 2024 |
| 972-P: Significant Weight Loss among People with Diabetes Despite Using Antidiabetic Medications Associated with Weight Gain after 90-Day Fitterfly Digital Therapeutics Program SA PATANGE, R VERMA, C SELVAN, S KALRA, MH TIWASKAR, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 971-P: Targeting Personalized Glycemic Response Led to Reduction in Glycemic Variability in Fitterfly CGM Diabetes Digital Therapeutics Program R VERMA, MA KHADER, T LATHIA, SR TANNA, SA PATANGE, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days (July, 10.1007/s13410-022-01111-1, 2022) R Verma, S Bhardwaj, T Lathia, S Kalra, R Ranadive, S Tanna, ... INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES 43 (3), 433-434, 2023 | | 2023 |
| Correction to: Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days R Verma, S Bhardwaj, T Lathia, S Kalra, R Ranadive, S Tanna, ... International Journal of Diabetes in Developing Countries 43 (3), 433-434, 2023 | | 2023 |
| Reduction in Diabetes Distress and Improvement in Sleep Quality correlating with Better Glycemic Control Within 90 Days on Fitterfly Diabetes Program T Lathia, N Verma, N Gupta, P Rajawat, A Srivastava, R Verma, G Chhaya, ... Endocrine Abstracts 90, 2023 | | 2023 |
| Unlock significant improvements in key metabolic parameters using Fitterfly diabetes program: Real world evidence from a 90-day digital therapeutics program. A Singal, S Kalra, T Lathia, R Verma, J Bhatt, K Rao Indian Journal of Endocrinology & Metabolism 26, 2022 | | 2022 |
| 693-P: Significant Changes in Dietary Behaviour, Glycemic Control, and Weight after Participation in Personalized Glycemic Response–Based Diabefly Program R Verma, MA Khader, RM Ranadive, S Budyal, AA Saraf, V Raskar, ... Diabetes 71 (Supplement_1), 2022 | | 2022 |
| 1133-P: High Prediabetes Risk and Associated Risk Factors in Indian Population Based on Online Prediabetes Risk Test R Verma, R Sahay, G Bantwal, S Kalra, AD Agnihotri, MH Tiwaskar, ... Diabetes 71 (Supplement_1), 2022 | | 2022 |
| 546-P: Video Call-Based Assessment of Physical Fitness through Diabefly Digital Therapeutics Program for People with T2D in India M Bhagat, AS Mandlekar, R Verma, SS Kulkarni, C Selvan, AD Modi, ... Diabetes 71 (Supplement_1), 2022 | | 2022 |
| Personalized glycemic response based Diabefly-Pro® digital therapeutics improves dietary patterns, glycemic control and reduces postprandial hyperglycemia in real-world settings S Joshi, R Verma, M Khader, S Nikte, S Ade, S Bandukwala, M Joshi, ... Endocrine Abstracts 81, 2022 | | 2022 |
